Journal article
Alendronate Therapy in Men With Primary Hyperparathyroidism
Abstract
OBJECTIVE: To determine the skeletal effects of alendronate therapy in men with primary hyperparathyroidism (PHPT) in comparison with those in postmenopausal women.
METHODS: There essentially are no published data on the effects of bisphosphonate therapy in men with PHPT. We previously conducted a double-blind, randomized, single- crossover trial of alendronate, 10 mg daily, in PHPT and reported that alendronate significantly increases bone …
Authors
Khan AA; Bilezikian JP; Kung A; Dubois SJ; Standish TI; Syed ZA
Journal
Endocrine Practice, Vol. 15, No. 7, pp. 705–713
Publisher
Elsevier
Publication Date
November 2009
DOI
10.4158/ep08178.orr
ISSN
1530-891X